Literature DB >> 24028654

Triterpenoid resinous metabolites from the genus Boswellia: pharmacological activities and potential species-identifying properties.

Yuxin Zhang1, Zhangchi Ning, Cheng Lu, Siyu Zhao, Jianfen Wang, Baoqin Liu, Xuegong Xu, Yuanyan Liu.   

Abstract

The resinous metabolites commonly known as frankincense or olibanum are produced by trees of the genus Boswellia and have attracted increasing popularity in Western countries in the last decade for their various pharmacological activities. This review described the pharmacological specific details mainly on anti-inflammatory, anti-carcinogenic, anti-bacterial and apoptosis-regulating activities of individual triterpenoid together with the relevant mechanism. In addition, species-characterizing triterpenic markers with the methods for their detection, bioavailability, safety and other significant properties were reviewed for further research.

Entities:  

Year:  2013        PMID： 24028654      PMCID： PMC3847453          DOI： 10.1186/1752-153X-7-153

Source DB:  PubMed          Journal:  Chem Cent J        ISSN： 1752-153X            Impact factor:   4.215


  104 in total

1.  A lupane triterpene from frankincense (Boswellia sp., Burseraceae).

Authors:  Gérald Culioli; Carole Mathe; Paul Archier; Cathy Vieillescazes
Journal:  Phytochemistry       Date:  2003-02       Impact factor: 4.072

Review 2.  Pharmacological activities of natural triterpenoids and their therapeutic implications.

Authors:  Petr Dzubak; Marian Hajduch; David Vydra; Alica Hustova; Miroslav Kvasnica; David Biedermann; Lenka Markova; Milan Urban; Jan Sarek
Journal:  Nat Prod Rep       Date:  2006-05-03       Impact factor: 13.423

3.  Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases.

Authors:  Tatiana Syrovets; Berthold Büchele; Christine Krauss; Yves Laumonnier; Thomas Simmet
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

4.  Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice.

Authors:  M Bishnoi; C S Patil; A Kumar; S K Kulkarni
Journal:  Methods Find Exp Clin Pharmacol       Date:  2005-09

Review 5.  Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.

Authors:  Mona Abdel-Tawab; Oliver Werz; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2011-06       Impact factor: 6.447

Review 6.  NSAID-induced nephrotoxicity from the fetus to the child.

Authors:  L Cuzzolin; M Dal Cerè; V Fanos
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.606

7.  Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome(®)) of Boswellia extract.

Authors:  Jan Hüsch; Janine Bohnet; Gert Fricker; Carsten Skarke; Christian Artaria; Giovanni Appendino; Manfred Schubert-Zsilavecz; Mona Abdel-Tawab
Journal:  Fitoterapia       Date:  2012-10-23       Impact factor: 2.882

8.  Cytochrome P450 expression in oesophageal cancer.

Authors:  G I Murray; D Shaw; R J Weaver; J A McKay; S W Ewen; W T Melvin; M D Burke
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 9.  Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion.

Authors:  Tongda Xu; Dongye Li; Dehua Jiang
Journal:  Nutrients       Date:  2012-12-12       Impact factor: 5.717

10.  Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata.

Authors:  Alsaba F Raja; Furqan Ali; Inshad A Khan; Abdul S Shawl; Daljit S Arora; Bhahwal A Shah; Subhash C Taneja
Journal:  BMC Microbiol       Date:  2011-03-16       Impact factor: 3.605
View more
  8 in total

1.  New ursane triterpenoids from Ficus pandurata and their binding affinity for human cannabinoid and opioid receptors.

Authors:  Amgad I M Khedr; Sabrin R M Ibrahim; Gamal A Mohamed; Hany E A Ahmed; Amany S Ahmad; Mahmoud A Ramadan; Atef E Abd El-Baky; Koji Yamada; Samir A Ross
Journal:  Arch Pharm Res       Date:  2016-06-27       Impact factor: 4.946

2.  Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial.

Authors:  Somayeh Mahmoodi Baram; Saeed Karima; Somayeh Shateri; Abbas Tafakhori; Akbar Fotouhi; Behnam Safarpour Lima; Shima Rajaei; Meisam Mahdavi; Hessam Sepasi Tehrani; Vajiheh Aghamollaii; Seyed Hossein Aghamiri; Behnam Mansouri; Sina Gharahje; Samaneh Kabiri; Maryamosadat Hosseinizadeh; Shima Zare Shahamati; Amir Taher Alborzi
Journal:  Inflammopharmacology       Date:  2019-08-12       Impact factor: 4.473

3.  In silico assay development for screening of tetracyclic triterpenoids as anticancer agents against human breast cancer cell line MCF7.

Authors:  Om Prakash; Ateeque Ahmad; Vinay Kumar Tripathi; Sudeep Tandon; Aditya Bhusan Pant; Feroz Khan
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

4.  Holy smoke in medieval funerary rites: chemical fingerprints of frankincense in southern Belgian incense burners.

Authors:  Jan Baeten; Koen Deforce; Sophie Challe; Dirk De Vos; Patrick Degryse
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

5.  Anti-aggregatory effect of boswellic acid in high-fat fed rats: involvement of redox and inflammatory cascades.

Authors:  Mona Kamal Tawfik
Journal:  Arch Med Sci       Date:  2016-06-20       Impact factor: 3.318

6.  Safety and efficacy of a feed additive consisting of an extract of olibanum from Boswellia serrata Roxb. ex Colebr. for use in dogs and horses (FEFANA asbl).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Paul Brantom; Andrew Chesson; Johannes Westendorf; Paola Manini; Fabiola Pizzo; Birgit Dusemund
Journal:  EFSA J       Date:  2022-03-07

7.  Protein Targets of Frankincense: A Reverse Docking Analysis of Terpenoids from Boswellia Oleo-Gum Resins.

Authors:  Kendall G Byler; William N Setzer
Journal:  Medicines (Basel)       Date:  2018-08-31

8.  Antioxidant, anti-inflammatory and anti-fibrotic effects of Boswellia serrate gum resin in CCl4-induced hepatotoxicity.

Authors:  Heba M Eltahir; Michael A Fawzy; Elhussein M Mohamed; Mahmoud A Alrehany; Ahmed M Shehata; Mekky M Abouzied
Journal:  Exp Ther Med       Date:  2019-12-19       Impact factor: 2.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.